Ching Hsu
Impact in
-
- Liver physiology and pathology
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Botulinum Toxin and Related Neurological Disorders
Papers in
- Oncology 8
- Colorectal Cancer Treatments and Studies 4
-
- Protein Degradation and Inhibitors 3
- Histone Deacetylase Inhibitors Research 3
- Co-authors
- Domenico Merante (4 shared papers)Uma Sharma (2 shared papers)Julio Rosenstock (2 shared papers)Hamim Zahir (7 shared papers)Stephen A. Cooper (1 shared paper)Byron Cryer (1 shared paper)Suman Wason (1 shared paper)Roger G. Berlin (1 shared paper)
- Journals
- Blood (3 papers)The Journal of Clinical Pharmacology (2 papers)Pain Medicine (1 paper)Investigational New Drugs (1 paper)Pain Research and Management (1 paper)
- Partner nations
- United StatesJapanGermany
In The Last Decade
Ching Hsu
23 papers receiving 350 citations
Peers
Comparison fields: 5 of 65
- Hepatology 44
- Neurology 84
- Internal Medicine 20
- Physiology 130
- Oncology 107
Countries citing papers authored by Ching Hsu
This map shows the geographic impact of Ching Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching Hsu more than expected).
Fields of papers citing papers by Ching Hsu
This network shows the impact of papers produced by Ching Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching Hsu. The network helps show where Ching Hsu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ching Hsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 79 | |
| 2 | 2016 | 52 | |
| 3 | 2005 | 30 | |
| 4 | 2017 | 29 | |
| 5 | 2019 | 26 | |
| 6 | 2018 | 23 | |
| 7 | 2013 | 22 | |
| 8 | 2011 | 14 | |
| 9 | 2018 | 14 | |
| 10 | 2016 | 13 | |
| 11 | 2018 | 9 | |
| 12 | 2023 | 8 | |
| 13 | 2022 | 5 | |
| 14 | 2023 | 5 | |
| 15 | 2023 | 4 | |
| 16 | 2019 | 4 | |
| 17 | Abstract 12074: A Randomized, Open-Label, Multicenter Study of the Efficacy and Safety of Edoxaban Monotherapy versus Low-Molecular Weight Heparin/Warfarin in Patients With Symptomatic Deep Vein Thrombosis - Edoxaban Thrombus Reduction Imaging Study (eTRIS) | 2014 | 4 |
| 18 | 2018 | 3 | |
| 19 | 2022 | 3 | |
| 20 | 2022 | 3 |
About Ching Hsu
Ching Hsu is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Hematology and Neurology, having authored 23 papers that have together received 356 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (4 papers), Venous Thromboembolism Diagnosis and Management (4 papers), Protein Degradation and Inhibitors (3 papers), Botulinum Toxin and Related Neurological Disorders (3 papers), Pain Mechanisms and Treatments (3 papers), Histone Deacetylase Inhibitors Research (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Hepatology (44 citations), Neurology (84 citations), Internal Medicine (20 citations), Physiology (130 citations) and Oncology (107 citations). Ching Hsu has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include Domenico Merante, Uma Sharma, Julio Rosenstock, Hamim Zahir, Stephen A. Cooper, Byron Cryer, Suman Wason, Roger G. Berlin, Lowell L. Hart and Reinhard von Roemeling. Their work appears in journals such as Blood, The Journal of Clinical Pharmacology, Pain Medicine, Investigational New Drugs and Pain Research and Management.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.